Medicine passport

LAMIVUDINA/ZIDOVUDINA TEVA 150 mg / 300 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Lamivudina + zidovudina
Strength
150 mg / 300 mg
Form
comprimido recubierto con película
ATC code
J05AR01
Registered in
Spain · Teva B.V.
Prescription
Prescription only
Nº Registro
10663001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 3 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
APO-LAMIVUDINE-ZIDOVUDINE150 mg + 300 mg · tabletPrescription onlyApotex Inc02375540
AURO-LAMIVUDINE/ZIDOVUDINE150 mg + 300 mg · tabletPrescription onlyAuro Pharma Inc02414414
JAMP LAMIVUDINE / ZIDOVUDINE150 mg + 300 mg · tabletPrescription onlyJamp Pharma Corporation02502801

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/es/en/medicines/lamivudina-zidovudina-teva-150-mg-300-mg-comprimido-recubierto-con-pelic